Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Debiopharm
Biotech
Repare finds suitor for PKMYT1 inhibitor in partner Debiopharm
Seven months after pressing pause on its plans for its PKMYT1 inhibitor, Repare Therapeutics has found a partner to take the cancer drug forward.
James Waldron
Jul 16, 2025 5:38am
Merck KGaA turns to BD to rapidly speed up pipeline progress
Nov 21, 2022 12:00pm
Merck KGaA pens $855M biobucks pact with Debiopharm
Mar 1, 2021 9:25am
Kaiku bags cash to show software improves cancer outcomes
Apr 6, 2018 9:25am
Jazz pays $75M for chance to buy into ImmunoGen ADCs
Aug 29, 2017 8:25am
Debiopharm buys ImmunoGen ADC to grow cancer pipeline
May 24, 2017 4:26am
